By Lucy Parkinson, Senior Research Manager, LSN
 Previous articles have provided overviews of innovation and investors in the cardiovascular, oncology, and neurology sectors. Infectious disease is also a major field of innovation; LSN researchers track 567 clinical-stage therapeutics globally that are targeting an infectious or parasitic disease.
Perhaps the most striking distinction of the infectious disease space, compared with sectors we've examined previously, is its breadth. The nature of the infectious disease field is one of constant change and local variation, with researchers focused on a multiplying array of threats throughout the world...

|